Bouthaina S. Dabaja, MD, FASTRO

Peer-Reviewed Articles

1. Manzar, G, Wu, SY, Dudzinski, SO, Cha, E, Yoder, A, Corrigan, KL, Nasr, L, Sallard, G, Ahmed, S, Fayad, LE, Chihara, D, Nair, R, Westin, JR, Daher, M, Neelapu, SS, Nastoupil, L, Gunther, J, Pinnix, CC, Dabaja, BS, Strati, P, Fang, PQ. Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy. International Journal of Radiation Oncology Biology Physics 121(4):1011-1025, 2025. e-Pub 2025. PMID: 39303997.
2. Wu SY, Damron EP, Xu J, Fang PQ, Dai J, Nair R, Malpica Castillo LE, Fayad LE, Torres-Cabala CA, Medeiros LJ, Vega F, Miranda RN, Duvic M, Pinnix CC, Dabaja BS, Iyer SP, Huen AO, Gunther JR. Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Int J Dermatol 64(2):385-389, 2025. e-Pub 2025. PMID: 38955474.
3. Manzar, G, Pinnix, CC, Dudzinski, SO, Marqueen, KE, Cha, E, Nasr, L, Yoder, A, Rooney, MK, Strati, P, Ahmed, S, Nze, CC, Nair, R, Fayad, LE, Wang, L, Nastoupil, L, Westin, JR, Flowers, CR, Neelapu, SS, Gunther, J, Dabaja, BS, Wu, SY, Fang, PQ. Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas. Frontiers in immunology 16, 2025. e-Pub 2025.
4. Fang, PQ, Noticewala, SS, Wu, SY, Gunther, J, Ludmir, EB, Medeiros, LJ, Strati, P, Nair, R, Nze, CC, Nastoupil, L, Ahmed, S, Castillo, LM, Fayad, LE, Westin, J, Neelapu, SS, Flowers, CR, Huen, A, Iyer, SP, Dabaja, BS, Pinnix, CC. Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type. Advances in Radiation Oncology 9(12), 2024. e-Pub 2024. PMID: 39553398.
5. Wu, SY, Fang, PQ, Fetooh, A, Manzar, G, Corrigan, KL, Schrank, BR, Nasr, L, Chihara, D, Castillo, LM, Nair, R, Steiner, RE, Jain, P, Neelapu, SS, Strati, P, Nastoupil, L, Dabaja, BS, Pinnix, CC, Gunther, J. Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. Advances in Radiation Oncology 9(12), 2024. e-Pub 2024. PMID: 39524525.
6. Purnak, S, Hosing, C, Dabaja, BS, Bassett Jr, R, Huen, A, Duvic, M. On the Way to Curing Advanced-Stage Mycosis Fungoides/Sézary Syndrome. Clinical Lymphoma, Myeloma and Leukemia 24(12):827-836, 2024. e-Pub 2024. PMID: 39107202.
7. Goyal, A, O'Leary, D, Dabaja, BS, Weng, WK, Zain, J, Cutler, C, Guitart, J, Kim, YH, Geskin, L, Hoppe, RT, Wilson, LD, Beaven, A, Horwitz, SM, Allen, PB, Barta, S, Bohjanen, K, Brammer, JE, Carter, JB, Comfere, N, Desimone, JA, Dusenbery, K, Duvic, M, Huen, A, Jagadeesh, D, Kelsey, CR, Khodadoust, MS, Lechowicz, MJ, Mehta-Shah, N, Moskowitz, AJ, Olsen, EA, Poh, C, Pro, B, Querfeld, C, Sauter, C, Sokol, L, Sokumbi, O, Wilcox, RA, Zic, J, Hamadani, M, Foss, FM. ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome. Transplantation and Cellular Therapy 30(11):1047-1060, 2024. e-Pub 2024. PMID: 39222792.
8. Zhang JR, Wu SY, Jain P, Ok CY, Yan F, Chen W, Oriabure O, Dabaja B, Gunther J, Fang P, Pinnix C, Wang ML, Gaulin C. Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer center. Leuk Lymphoma 11:1729-1732, 2024. e-Pub 2024. PMID: 38972059.
9. Pinnix CC, Dabaja BS, Gunther JR, Fang PQ, Wu SY, Nastoupil LJ, Strati P, Nair R, Ahmed S, Steiner R, Westin J, Neelapu S, Rodriguez MA, Lee HJ, Wang M, Flowers C, Feng L, Esmaeli B. Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial. JAMA Oncol 10(9):1195-1203, 2024. e-Pub 2024. PMID: 38990564.
10. Gunther JR, Xu J, Bhutani MS, Strati P, Fang PQ, Wu SY, Dabaja BS, Dong W, Bhosale PR, Flowers CR, Nair R, Malpica Castillo L, Fayad L, Iyer SP, Parmer S, Wang M, Lee HJ, Samaniego F, Westin J, Ahmed S, Nze CC, Jain P, Neelapu SS, Rodriguez MA, Chihara D, Nastoupil LJ, Pinnix CC. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial. Lancet Haematol 11(7):e521-e529, 2024. e-Pub 2024. PMID: 38843856.
11. Fang P, Pinnix CC, Wu SY, Lee HC, Patel KK, Saini N, Becnel MR, Kaufman G, Thomas SK, Orlowski RZ, Amini B, Lin P, Dabaja BS, Gunther JR. Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys 119(1):193-199, 2024. e-Pub 2024. PMID: 38070713.
12. Manzar, G, Cha, E, Corrigan, KL, Yoder, A, Schrank, BR, Nasr, L, Chihara, D, Castillo, LM, Nair, R, Jain, P, Neelapu, SS, Rodriguez, MA, Strati, P, Nastoupil, L, Gunther, J, Dabaja, BS, Pinnix, CC, Wu, SY, Fang, PQ. Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs. Frontiers in Oncology 14, 2024. e-Pub 2024. PMID: 39324011.
13. Steiner RE, Hwang SR, Khurana A, Habermann TM, Epperla N, Annunzio K, Allen PB, Baird K, Paulino D, Alderuccio JP, Lossos IS, David K, Evens AM, Pandya K, Bair SM, Kamdar M, Ba Aqeel S, Torka P, Lynch R, Smith S, Feng L, Noorani M, Ahmed S, Nair R, Vega F, Wu S, Fang P, Pinnix CC, Gunther JR, Dabaja BS, Lee HJ. Impact of Cumulative Dose of Brentuximab Vedotin on Outcomes of Frontline Therapy for Advanced Stage Hodgkin Lymphoma. Blood Adv 7(24):7485-7493, 2023. e-Pub 2023. PMID: 37603594.
14. Dabaja B. Radiation Therapy for Hematologic Malignancies. Oncology Times 45(21):1 and 5-11, 2023. e-Pub 2023.
15. Alkhaldi H, Reinhardt A, Barnett M, Kundu S, Hosing C, Ramdial J, Saini N, Srour S, Alousi A, Kebriaei P, Popat U, Qazilbash M, Champlin R, Shpall EJ, Gulbis A, Shigle TL, Dabaja B, Pinnix C, Ahmed S, Steiner R, Andersson BS, Nieto Y. High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma. Transplant Cell Ther 29(11):690-694, 2023. e-Pub 2023. PMID: 37607645.
16. Wilkinson, AJ, Nader, M, Roberts, DB, Duvic, M, Gunther, J, Dabaja, BS, Gidley, PW. Survival Outcomes of Patients with Mycosis Fungoides Involving the External Ear and Ear Canal. Laryngoscope 133(6):1486-1491, 2023. e-Pub 2023. PMID: 36054317.
17. El Hussein S, Medeiros LJ, Lyapichev KA, Fang H, Jelloul FZ, Fiskus W, Chen J, Wei P, Schlette E, Xu J, Li S, Kanagal-Shamanna R, Yang H, Tang Z, Thakral B, Loghavi S, Jain N, Thompson PA, Ferrajoli A, Wierda WG, Jabbour E, Patel KP, Dabaja BS, Bhalla KN, Khoury JD. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma. Pathology 55(4):514-524, 2023. e-Pub 2023. PMID: 36933995.
18. Kantarjian H, Haddad FG, Jain N, Sasaki K, Short NJ, Loghavi S, Kanagal-Shamanna R, Jorgensen J, Khouri I, Kebriaei P, Alvarado Y, Kadia T, Paul S, Garcia-Manero G, Dabaja B, Yilmaz M, Jacob J, Garris R, O'Brien S, Ravandi F, Jabbour E. Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia. J Hematol Oncol 16(1):44, 2023. e-Pub 2023. PMID: 37131217.
19. Afrough A, Alsfeld LC, Milton DR, Delgado R, Popat UR, Nieto Y, Kebriaei P, Oran B, Saini N, Srour S, Hosing C, Cheema FH, Ahmed S, Manasanch EE, Lee HC, Kaufman GP, Patel KK, Weber DM, Orlowski RZ, Pinnix CC, Dabaja BS, Thomas SK, Champlin RE, Shpall EJ, Qazilbash MH, Bashir Q. Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma. Transplant Cell Ther 29(4):264.e1-264.e9, 2023. e-Pub 2023. PMID: 35605883.
20. Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. e-Pub 2023. PMID: 36868753.
21. Kahn JM, Yang JC, Yahalom J, Dabaja BS, Vapiwala N, Hoppe BS, Tseng YD, Pinnix CC, Parikh RR, Sim AJ, Plastaras JP, Gunther JR, Steering Committee WTIE, Committee AE. Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report. J Cancer Educ 38(1):201-205, 2023. e-Pub 2023. PMID: 34601699.
22. Wu SY, Fang PQ, Wang EB, Ahmed S, Duvic M, Jain P, Castillo LEM, Nair R, Steiner RE, Strati P, Huen AO, Iyer SP, Pinnix CC, Dabaja BS, Gunther JR. Safety of Concurrent Radiation Therapy with Brentuximab Vedotin in the Treatment of Lymphoma. Adv Radiat Oncol 8(6):101279, 2023. e-Pub 2023. PMID: 37448588.
23. Dabaja BS, Ng AK. Let us give our Hodgkin's lymphoma patients the radiation they need. Leuk Lymphoma 63(12):1-2, 2022. e-Pub 2022. PMID: 36107106.
24. Bidikian, A, Kantarjian, HM, Dabaja, BS, Ravandi-Kashani, F, Jabbour, EJ, DiNardo, C, Borthakur, G, Daver, N, Garcia-Manero, G, Kadia, TM, Sasaki, K, Issa, GC. AML-285 Association Between Myeloid Malignancies With MECOM Rearrangement and Ocular Adnexal Leukemic Infiltration. Clinical Lymphoma, Myeloma and Leukemia 22:S233-S234, 2022. e-Pub 2022. PMID: 36163805.
25. Akin S, Hosing C, Khouri I, Ahmed S, Alousi A, Fowler N, Joseph J, Truxillo J, Ramdial JL, Maadani F, Rondon G, Daher M, Im JS, Steiner R, Westin J, Iyer SP, Dabaja B, Anderlini P, Popat UR, Qazilbash MH, Flowers CR, Shpall E, Champlin RE, Nieto Y, Srour SA. Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement. Blood Adv 6(7):2267-2274, 2022. e-Pub 2022. PMID: 35008100.
26. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Chen W, Dabaja B, Daly ME, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Johnston PB, Kaminski MS, Kelsey CR, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, Metzger M, Morgan D, Mulroney C, Pullarkat ST, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Torka P, Winter JN, Yahalom J, Yang JC, Burns JL, Campbell M, Sundar H. NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022. J Natl Compr Canc Netw 20(4):322-334, 2022. e-Pub 2022. PMID: 35390768.
27. Nieto Y, Gruschkus S, Valdez BC, Jones RB, Anderlini P, Hosing C, Popat U, Qazilbash M, Kebriaei P, Alousi A, Saini N, Srour S, Rezvani K, Ramdial J, Barnett M, Gulbis A, Shigle TL, Ahmed S, Iyer S, Lee H, Nair R, Parmar S, Steiner R, Dabaja B, Pinnix C, Gunther J, Cuglievan B, Mahadeo K, Khazal S, Chuang H, Champlin R, Shpall EJ, Andersson BS. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica 107(4):899-908, 2022. e-Pub 2022. PMID: 33951890.
28. Gunther JR, Yang JC, Hajj C, Ng AK, Brady JL, Cheng S, Levis M, Qi S, Mikhaeel G, Ricardi U, Illidge T, Turin A, Knafl M, Specht L, Dabaja B, Yahalom J. Efficacy and Toxicity of Alternative Radiation Treatment Schemes for Patients with Hematologic Malignancies: A Collaborative ILROG COVID Era Report. Int J Radiat Oncol Biol Phys 111(3S):e308-e309, 2021. e-Pub 2021. PMID: 34701145.
29. Wu SY, Fang P, Huen AO, Iyer SP, Nair R, Steiner R, Castillo LEM, Duvic M, Ahmed S, Jain P, Fayad L, Strati P, Westin J, Neelapu SS, Nastoupil L, Pinnix CC, Dabaja B, Gunther JR. Concurrent Radiation Therapy with the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin. Int J Radiat Oncol Biol Phys 111(3S):e301, 2021. e-Pub 2021. PMID: 34701130.
30. Damron EP, Qazilbash M, Fang P, Wu SY, Dabaja B, Rondon G, Hosing C, Champlin R, Bashir Q, Shpall EJ, Knafl M, Lee H, Manasanch EE, Patel K, Kaufman G, Thomas S, Orlowski R, Weber D, Pinnix CC, Gunther JR. Radiation Therapy can be Safely Incorporated into Pre-Transplant Treatment Regimens for Patients With Multiple Myeloma. Int J Radiat Oncol Biol Phys 111(3S):S81, 2021. e-Pub 2021. PMID: 34700640.
31. Tran KH, Tsang RW, Suh CO, Yoon HI, Taguchi S, Oguchi M, Gunther JR, Dabaja B, Wright CM, Plastaras JP, Elsayad K, Ng AK, Binkley MS, Brady JL, Wang X, Levis M, Harris M, Bressel M, MacManus MP, Wirth A. An International, Multi-Centre Study of Radiotherapy for Bilateral Indolent Orbital Adnexal Lymphomas (IOAL). Int J Radiat Oncol Biol Phys 111(3S):S104-S105, 2021. e-Pub 2021.
32. Al Feghali KA, Fang P, Gule-Monroe M, Milgrom S, Khoury JD, Gunther JR, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Shpall EJ, Nieto YL, Hosing C, Nastoupil LJ, Westin JR, Neelapu SS, Fowler N, Flowers C, Pinnix CC, Dabaja BS. Prognostic Value of Disease Distribution in Secondary Central Nervous System Diffuse Large B Cell Lymphoma Treated with Radiation Therapy. Leuk Lymphoma 62(10):1-8, 2021. e-Pub 2021. PMID: 33942701.
33. S Mehta R, Torres Cabala CA, DiNardo CD, Daver N, Dabaja B, Rezvani K, Champlin RE, Shpall E, Duvic M. Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant Hemophagocytic lymphohistiocytosis. Am J Hematol 96(9):E350-E353, 2021. e-Pub 2021. PMID: 34096089.
34. Qi SN, Li YX, Specht L, Oguchi M, Tsang R, Ng A, Suh CO, Ricardi U, Mac Manus M, Dabaja B, Joachim Y. Modern Radiation Therapy for Extranodal Nasal-Type NK/T cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 110(4):1064-1081, 2021. e-Pub 2021. PMID: 33581262.
35. Qi SN, Li YX, Specht L, Oguchi M, Tsang R, Ng A, Suh CO, Ricardi U, MacManus M, Dabaja B, Yaholom J. Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 110(4):1064-1081, 2021. e-Pub 2021. PMID: 33581262.
36. Qi SN, Li YX, Specht L, Oguchi M, Tsang R, Ng A, Suh CO, Ricardi U, MacManus M, Dabaja B, Yahalom J. Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 110(4):1064-1081, 2021. e-Pub 2021.
37. Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, Nair R, Steiner RE, Iyer SP, Rodriguez A, Fayad LE, Flowers CR, Dabaja BS, Pinnix CC. The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leuk Lymphoma 62(6):1-12, 2021. e-Pub 2021. PMID: 33480830.
38. Jabbour E, Sasaki K, Short NJ, Ravandi F, Huang X, Khoury JD, Kanagal-Shamanna R, Jorgensen J, Khouri IF, Kebriaei P, Jain N, Alvarado Y, Kadia TM, Paul S, Garcia-Manero G, Dabaja BS, Burger JA, DiNardo CD, Daver NA, Montalban-Bravo G, Yilmaz M, Ohanian M, Ferrajoli A, Jacob J, Rostykus M, Garris R, O'Brien S, Kantarjian HM. Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Cancer 127(12):2025-2038, 2021. e-Pub 2021. PMID: 33740268.
39. Ballas LK, Metzger ML, Milgrom SA, Advani R, Bakst RL, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Pinnix CC, Plastaras JP, Roberts KB, Smith SM, Terezakis SA, Constine LS. Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria. Leuk Lymphoma 62(5):1-14, 2021. e-Pub 2021. PMID: 33274673.
40. Ning MS, Das P, Rosenthal DI, Dabaja BS, Liao Z, Chang JY, Gomez DR, Klopp AH, Gunn GB, Allen PK, Nitsch PL, Natter RB, Briere TM, Herman JM, Wells R, Koong AC, McAleer MF. Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care. J Natl Compr Canc Netw 19(7):1-9, 2021. e-Pub 2021. PMID: 33878727.
41. Fang P, Gunther JR, Pinnix CC, Dong W, Strati P, Nastoupil LJ, Steiner RE, Ahmed S, Damron EP, Fowler N, Nair R, Westin JR, Neelapu S, Ha CS, Dabaja BS. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys 109(5):1414-1420, 2021. e-Pub 2021. PMID: 33309978.
42. Strati P, Cheng PTM, Steiner RE, Alcedo Andrade PE, Feng L, Sano D, Rao VA, Singh P, Miranda R, Gunther JR, Pinnix CC, Dabaja BS, Cuglievan B, Xing K, Villa D, Skinnider B, Sehn LH, Connors JM, Nieto Y, Ahmed S, Lee HJ, Savage KJ. Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis. Br J Haematol 192(3):560-567, 2021. e-Pub 2021. PMID: 33517581.
43. Manasanch EE, Kunacheewa C, Claussen CM, Lee HC, Thomas SK, Gunther J, Pinnix CC, Dabaja BS, Amini B, Alexanian R, Orlowski RZ, Dong W, Feng L, Weber DM. Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up. Blood Cancer J 11(2):17, 2021. e-Pub 2021. PMID: 33563896.
44. Dabaja BS, Milgrom SA, Wirth A. Secondary central nervous system diffuse large cell lymphoma: an opportunity for radiation therapy to improve outcomes. Leuk Lymphoma 62(1):1-4, 2021. e-Pub 2021. PMID: 33356706.
45. Morse DC, Park KE, Chitsazzadeh V, Li S, Young K, Gunther JR, Dabaja BS, Duvic M. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. Int J Gynecol Pathol 40(3):229-233, 2021. e-Pub 2021. PMID: 33741766.
46. Furqan F, Watson G, Samaniego F, Fayad LE, Kanagal-Shamanna R, Morrison MW, Thompson PA, Steiner RE, Chi L, Dabaja B Pinnix CC, Neelapu SS, Nastoupil LJ, Strati P. Ibrutinib-Based Therapy for the Treatment of Marginal Zone Lymphoma with Central Nervous System Involvement. Leuk Lymphoma 61(12):1-5, 2020. e-Pub 2020. PMID: 32650677.
47. Specht L, Wong JYC, Filippi AR, Dabaja BS, Yahalom J. In Reply to Scarpelli et al. Int J Radiat Oncol Biol Phys 108(5):1396, 2020. e-Pub 2020. PMID: 33220231.
48. Dabaja BS, Ng AK, Terezakis SA, Plastaras JP, Yunes M, Wilson LD, Yang J, Gunther JR, Specht L, Yahalom J. ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 108(4):977-978, 2020. e-Pub 2020. PMID: 32768256.
49. Moreno AC, Gunther JR, Milgrom S, Fuller CD, Williamson T, Liu A, Wu R, Zhu XR, Dabaja BS, Pinnix CC. Effect of Deep Inspiration Breath Hold on Normal Tissue Sparing with Intensity Modulated Radiation Therapy Versus Proton Therapy for Mediastinal Lymphoma. Adv Radiat Oncol 5(6):1255-1266, 2020. e-Pub 2020. PMID: 33305086.
50. Zhu LL, Martin RM, Gunther JR, Wong PF, Hancock D, Moreno AC, Dabaja BS, Pinnix CC. Daily computed tomography image guidance: dosimetric advantages outweigh low-dose radiation exposure for treatment of mediastinal lymphoma. Radiother Oncol 152:14-18, 2020. e-Pub 2020. PMID: 32593645.
51. Christopherson KM, Gunther JR, Fang P, Peterson SL, Roach KE, Wong PF, Mirkovic D, Lim TY, Wang H, Wang XA, Wang C, Garcia J, Dabaja BS, Pinnix CC. Decreased heart dose with deep inspiration breath hold for the treatment of gastric lymphoma with IMRT. Clin Transl Radiat Oncol 24:79-82, 2020. e-Pub 2020. PMID: 32642563.
52. Pinnix CC, Gunther JR, Fang P, Bankston ME, Milgrom SA, Boyce D, Lee HJ, Nair R, Steiner R, Strati P, Ahmed S, Iyer SP, Westin J, Parmar S, Rodriguez MA, Nastoupil L, Neelapu S, Flowers C, Dabaja BS. Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy. JAMA Netw Open 3(9):e2013935, 2020. e-Pub 2020. PMID: 32990738.
53. Wirth A, Mikhaeel NG, Aleman BMP, Pinnix CC, Constine LS, Ricardi U, Illidge TM, Eich HT, Hoppe BS, Dabaja B, Ng AK, Kirova Y, Berthelsen AK, Dieckmann K, Yahalom J, Specht L. Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines. Int J Radiat Oncol Biol Phys 107(5):909-933, 2020. e-Pub 2020.
54. Glober G, Gunther J, Fang P, Milgrom S, Korivi BR, Jensen CT, Wagner-Bartak NA, Ahmed S, Lee HJ, Nair R, Steiner R, Parmar S, Iyer S, Westin J, Fayad L, Rodriguez MA, Neelapu S, Nastoupil L, Flowers CR, Dabaja BS, Pinnix CC. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission. Clin Lymphoma Myeloma Leuk 20(8):533-541, 2020. e-Pub 2020. PMID: 32291233.
55. Dabaja B, Milgrom S, Parikh R, Wu S, Tsang R. The challenges of applying radiation in primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys 107(3):398-400, 2020. e-Pub 2020. PMID: 32531380.
56. Gunther JR, Pinnix CC, Glober GR, Christopherson KM, Fang P, Lee HJ, Ahmed S, Steiner RE, Nair R, Strati P, Neelapu SS, Nastoupil LJ, Dabaja BS. Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?. EJHaem 1(1):272-276, 2020. e-Pub 2020. PMID: 32864660.
57. Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
58. Ning MS, McAleer MF, Jeter MD, Minsky BD, Ghafar RA, Robinson IJ, Nitsch PL, Zaebst DJ, Todd SE, Nguyen J, Lin SH, Liao Z, Lee P, Gunn GB, Klopp AH, Dabaja BS, Nguyen QN, Chronowski GM, Bloom ES, Koong AC, Das P. Mitigating the Impact of COVID-19 on Oncology: Clinical and Operational Lessons from a Prospective Radiation Oncology Cohort Tested for COVID-19. Radiother Oncol 148:252-257, 2020. e-Pub 2020. PMID: 32474129.
59. Elhammali A, Amini B, Ludmir EB, Gunther JR, Milgrom SA, Pinnix CC, Andraos T, Yoder A, Weber D, Orlowski R, Manasanch E, Patel K, Strati P, Nair R, Lee HC, Thomas S, Iyer S, Kaufmann G, Garg N, Dabaja BS. New Paradigm for Radiation in Multiple Myeloma: Lower yet effective dose to avoid radiation toxicity. Haematologica 105(7):e355-e357, 2020. e-Pub 2020. PMID: 31919088.
60. Pinnix CC, Gunther JR, Dabaja BS, Strati P, Fang P, Hawkins MC, Adkins S, Westin J, Ahmed S, Fayad L, Lee HJ, Nair R, Steiner RE, Iyer SP, Rodriguez MA, Wang M, Flowers C, Neelapu SS, Nastoupil LJ. Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma. Blood Adv 4(13):2871-2883, 2020. e-Pub 2020. PMID: 32589728.
61. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Bierman PJ, Boughan KM, Dabaja B, Gordon LI, Hernandez-Ilizaliturri FJ, Herrera AF, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, McKinney M, Metzger M, Morgan D, Mulroney C, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 18(6):755-781, 2020. e-Pub 2020. PMID: 32502987.
62. Qi S, Milgrom S, Dabaja B, Tsang R, Levis M, Ricardi U, Lopez-Alonso R, Dann EJ, Ng A, Yahalom J. Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease. Blood Adv 4(9):2064-2072, 2020. e-Pub 2020. PMID: 32396621.
63. Yahalom J, Dabaja BS, Ricardi U, Ng A, Mikhaeel NG, Vogelius IR, Illidge T, Qi S, Wirth A, Specht L. ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic. Blood 135(21):1829-1832, 2020. e-Pub 2020. PMID: 32275740.
64. Dabaja BS, Ng AK, Terezakis SA, Plastaras JP, Yunes M, Wilson LD, Specht L, Yahalom J. Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies. Int J Radiat Oncol Biol Phys 106(2):279-281, 2020. e-Pub 2020. PMID: 31928641.
65. Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Lee HJ, Fowler N, Nastoupil L, Neelapu SS, Pinnix CC. Radiation therapy for salivary gland MALT lymphoma: Ultra-low dose treatment achieves encouraging early outcomes and spares salivary function. Leuk Lymphoma 61(1):1-5, 2020. e-Pub 2020. PMID: 31373240.
66. Sunderland AJ, Steiner RE, Al Zahrani M, Pinnix CC, Dabaja BS, Gunther JR, Nastoupil LJ, Jerkeman M, Joske D, Cull G, El-Galaly T, Villa D, Cheah CY. An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement. Cancer Med 9(2):663-670, 2020. e-Pub 2020. PMID: 31808316.
67. Dabaja B. Would Negative Interim PET Be Enough to Omit Radiation in Patients with Early Hodgkin Lymphoma? The Answer Is No. Int J Radiat Oncol Biol Phys 106(1):16-17, 2020. e-Pub 2020. PMID: 31836077.
68. Andraos TY, Ayoub Z, Nastoupil LJ, Milgrom SA, Pinnix CC, Ng SP, Gunther JR, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Dabaja BS. Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma. Leuk Lymphoma 60(13):1-8, 2019. e-Pub 2019. PMID: 31234671.
69. Milgrom SA, Varghese B, Gladish GW, Choi AD, Dong W, Patel ZS, Chung CC, Rao A, Pinnix CC, Gunther JR, Dabaja BS, Lin SH, Hoffman KE, Huff JL, Slagowski J, Abe JI, Iliescu CA, Banchs J, Yusuf SW, Lopez-Mattei JC. Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy. J Cardiovasc Imaging 27(4):268-279, 2019. e-Pub 2019. PMID: 31614398.
70. Ayoub Z, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS, Ng SP, Gunther JR, Khoury JD, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Nastoupil LJ. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy. Leuk Lymphoma 60(10):1-9, 2019. e-Pub 2019. PMID: 30942648.
71. Elhammali A, Milgrom SA, Amini B, Gunther JR, Yoder A, Ludmir EB, Moon B, Weber DM, Thomas SK, Garg N, Manasanch EE, Patel KK, Orlowski RZ, Lee HC, Bird JE, Satcher R, Lin P, Pinnix CC, Dabaja BS. Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?. Clin Lymphoma Myeloma Leuk 19(8):e465, 2019. e-Pub 2019. PMID: 31133526.
72. Binkley MS, Brady JL, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Ahmed S, MacManus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova YM, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Mikhaeel NG, Hoppe RT. Salvage treatment and survival for relapsed follicular lymphoma following primary radiotherapy: A collaborative study on behalf of ILROG. Int J Radiat Oncol Biol Phys 104(3):522-529, 2019. e-Pub 2019. PMID: 30858143.
73. Ning MS, Pinnix CC, Chapman BV, Gunther JR, Milgrom SA, Khoury JD, Jain P, Chen WY, Oriabure ON, Badillo MR, Wang LM, Dabaja BS. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. Blood Adv 3(13):2035-2039, 2019. e-Pub 2019. PMID: 31289030.
74. Strati P, Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister FB, Romaguera J, Fayad LE, Rodriguez MA, Samaniego F, Fowler N, Westin J, Wang M, Lee HJ, Pinnix C, Gunther JR, Dabaja B, Feng L, Davis RE, Neelapu SS. Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma. Am J Hematol 94(6):E150-E153, 2019. e-Pub 2019. PMID: 30785215.
75. Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee HJ, Westin J, Fowler N, Nastoupil L, Dabaja B. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa- Associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys 104(2):447-455, 2019. e-Pub 2019. PMID: 30769175.
76. Andraos T, Ayoub Z, Nastoupil L, Pinnix C, Milgrom S, Gunther J, Ng SP, Fowler N, Neelapu S, Samaniego F, Dabaja B. Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes. Clin Lymphoma, Myeloma & Leuk 19(6):381-389, 2019. e-Pub 2019.
77. Yoder AK, Gunther JR, Milgrom SA, Pham M, Hancock D, McSpadden K, Garcia J, Mirkovic D, Dabaja BS, Pinnix CC. Rainbow IMRT and Volumetric Imaging for Anterior Mesenteric Targets. Pract Radiat Oncol 9(3):147-152, 2019. e-Pub 2019. PMID: 30708131.
78. Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Yehia Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head Neck 41(5):1546, 2019. e-Pub 2019. PMID: 30990235.
79. Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, Samaniego F, Rodriguez MA, Rich AE, Medeiros LJ, Dabaja BS. Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood Adv 3(9):1356-1367, 2019. e-Pub 2019. PMID: 31036721.
80. Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE, Khoury JD, Medeiros LJ, Dabaja BS, Nastoupil LJ. Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue. Clin Lymphoma Myeloma Leuk 19(4):244-250, 2019. e-Pub 2019. PMID: 30686775.
81. Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma. Sci Rep 9(1):1322, 2019. e-Pub 2019. PMID: 30718585.
82. An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BS. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides. Radiother Oncol 131:88-92, 2019. e-Pub 2019. PMID: 30773193.
83. Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, Ahmed S, Medeiros LJ, Khoury JD, Garg N, Amini B, Dabaja BS, Pinnix CC. Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery with Volumetric Image-guided Intensity Modulated Radiation Therapy. Clin Lymphoma Myeloma Leuk 19(1):e51-e61, 2019. e-Pub 2019. PMID: 30360985.
84. Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Hoppe RT, Mikhaeel NG. Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: A collaborative study by ILROG. Blood 133(3):237-245, 2019. e-Pub 2019. PMID: 30446493.
85. Milgrom SA, Pinnix CC, Gunther JR, Fanale M, Dabaja BS. Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma: Response to Adams and Kwee. Br J Haematol 184(2):292-293, 2019. e-Pub 2019. PMID: 29265334.
86. Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Hoppe RT, Mikhaeel NG. Definitive radiotherapy for localized follicular lymphoma staged by18F-FDG PET-CT: A collaborative study by ILROG. Blood 133(3):237-245, 2019. e-Pub 2019.
87. Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Oki Y, Fayad LE, Medeiros LJ, Dabaja BS, Nastoupil LJ. Primary Breast Diffuse Large B-Cell Lymphoma: Treatment Strategies and Patterns of Failure. Leuk Lymphoma 59(12):1-8, 2018. e-Pub 2018. PMID: 29697005.
88. Pinnix CC, Wirth A, Milgrom SA, Andraos TY, Aristophanous M, Pham M, Hancock D, Ludmir EB, Gunther JR, Fanale MA, Oki Y, Nastoupil L, Chuang HH, Mikhaeel NG, Dabaja BS. Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy. Leuk Lymphoma 59(11):1-10, 2018. e-Pub 2018. PMID: 29616834.
89. Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, Ahmed S, Alousi AM, Dabaja B, Pinnix CC. Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy. Adv Radiat Oncol 3(4):639-646, 2018. e-Pub 2018. PMID: 30370365.
90. Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampouri S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J. Proton Therapy for Adults with Mediastinal Lymphomas: The International Lymphoma Radiation Oncology Group (ILROG) Guidelines. Blood 132(16):1635-1646, 2018. e-Pub 2018. PMID: 30108066.
91. Jensen GL, Dabaja BS, Pinnix CC, Gunther JR, Huen A, Duvic M, Oki Y, Fanale M, Hosing C, Milgrom SA. Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement. Case Rep Oncol 11(3):721-728, 2018. e-Pub 2018. PMID: 30519174.
92. Nieto Y, Thall PF, Ma J, Valdez BC, Ahmed S, Anderlini P, Popat U, Jones RB, Shpall EJ, Hosing C, Qazilbash M, Kebriaei P, Alousi A, Timmons M, Gulbis A, Myers A, Oki Y, Fanale M, Dabaja B, Pinnix C, Milgrom S, Champlin R, Andersson BS. Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma. Biol Blood Marrow Transplant 24(8):1602-1609, 2018. e-Pub 2018. PMID: 29501779.
93. Pinnix CC, Huo J, Milgrom SA, Yehia ZA, Fanale M, Oki Y, Dabaja BS, Smith GL. Using Benchmarked Lung Radiation Dose Constraints to Predict Pneumonitis Risk: Developing a Nomogram for Patients with Mediastinal Lymphoma. Adv Radiat Oncol 3(3):372-381, 2018. e-Pub 2018. PMID: 30202805.
94. Pinnix CC, Cella L, Andraos TY, Ayoub Z, Milgrom SA, Gunther J, Thosani S, Wogan C, Conson M, D'Avino V, Oki Y, Fanale M, Lee HJ, Neelapu S, Fayad L, Hagemeister F, Rodriguez MA, Nastoupil LJ, Nieto Y, Qiao W, Pacelli R, Dabaja B. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy. Int J Radiat Oncol Biol Phys 101(3):530-540, 2018. e-Pub 2018. PMID: 29681481.
95. Pinnix CC, Ng AK, Dabaja BS, Milgrom SA, Gunther JR, Fuller CD, Smith GL, Abou Yehia Z, Qiao W, Wogan CF, Akhtari M, Mawlawi O, Medeiros LJ, Chuang HH, Martin-Doyle W, Armand P, LaCasce AS, Oki Y, Fanale M, Westin J, Neelapu S, Nastoupil L. Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Adv 2(11):1334-1343, 2018. e-Pub 2018. PMID: 29895624.
96. RLMC A, Loghavi S, Zuo Z, Fayad L, Dabaja B, Medeiros LJ, Khoury JD. Bone Marrow Involvement in Patients with Nodular Lymphocyte Predominant Hodgkin Lymphoma. Am J Surg Pathol 42(4):492-499, 2018. e-Pub 2018. PMID: 29309302.
97. Milgrom SA, Pinnix CC, Chi TL, Vu TH, Gunther JR, Sheu T, Fowler N, Westin JR, Nastoupil LJ, Oki Y, Fayad LE, Neelapu S, Rodriguez MA, Hagemeister FB, Fanale MA, Lee HJ, Hosing C, Ahmed S, Nieto Y, Shpall EJ, Dabaja BS. Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma. Int J Radiat Oncol Biol Phys 100(5):1146-1154, 2018. e-Pub 2018. PMID: 29452771.
98. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. J Natl Compr Canc Netw 16(3):245-254, 2018. e-Pub 2018. PMID: 29523663.
99. Reddy JP, Hernandez M, Gunther JR, Dabaja BS, Martin GV, Jiang W, Akhtari M, Allen PK, Atkinson BJ, Smith GL, Pinnix CC, Milgrom SA, Abou Yehia Z, Osborne EM, Oki Y, Lee H, Hagemeister F, Fanale MA. Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early-stage classical Hodgkin lymphoma. Br J Haematol 180(4):545-549, 2018. e-Pub 2018. PMID: 29271057.
100. Brammer JE, Chihara D, Poon LM, Caimi P, de Lima M, Ledesma C, Rondon G, Ciurea SO, Nieto Y, Fanale M, Dabaja B, Maziarz RT, Champlin RE, Hosing C, Oki Y. Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes. Clin Lymphoma Myeloma Leuk 18(1):e41-e59, 2018. e-Pub 2018. PMID: 29277360.
101. Aristophanous M, Chi PM, Kao J, Williamson R, Tung S, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS. Deep-Inspiration Breath-Hold Intensity Modulated Radiation Therapy to the Mediastinum for Lymphoma Patients: Setup Uncertainties and Margins. Int J Radiat Oncol Biol Phys 100(1):254-262, 2018. e-Pub 2018. PMID: 29100788.
102. Akhtari M, Milgrom SA, Pinnix CC, Reddy JP, Dong W, Smith GL, Mawlawi O, Abou Yehia Z, Gunther J, Osborne EM, Andraos TY, Wogan CF, Rohren E, Garg N, Chuang H, Khoury JD, Oki Y, Fanale M, Dabaja BS. Re-classifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood 131(1):84-94, 2018. e-Pub 2018. PMID: 29038339.
103. Abaza Y, M Kantarjian H, Faderl S, Jabbour E, Jain N, Thomas D, Kadia T, Borthakur G, D Khoury J, Burger J, Wierda W, O'Brien S, Konopleva M, Ferrajoli A, Kebriaei P, Dabaja B, Kornblau S, Alvarado Y, Daver N, Pemmaraju N, Bose P, Thompson P, Al Azzawi H, Kelly M, Garris R, Jain P, Garcia-Manero G, Cortes J, Ravandi F. Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma. Am J Hematol 93(1):91-99, 2018. e-Pub 2018. PMID: 29047158.
104. Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA. Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms. Onco Targets Ther 11:8937-8942, 2018. e-Pub 2018. PMID: 30573980.
105. Aristophanous M, Chi PCM, Kao J, Williamson R, Tung S, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS. DIBH-IMRT treatment to the mediastinum for lymphoma patients: Setup uncertainties and margins. Int J Radiat Oncol Biol Phys 100(1):254-262, 2018. e-Pub 2018.
106. Ho JC, Dabaja BS, Milgrom SA, Smith GL, Reddy JP, Mazloom A, Young KH, Deng L, Medeiros LJ, Dong W, Allen PK, Andraos TY, Fowler NH, Nastoupil LJ, Oki Y, Fayad LE, Turturro F, Neelapu SS, Westin J, Hagemeister FB, Rodriguez MA, Pinnix CC. Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma. Leuk Lymphoma 58(12):2833-2844, 2017. e-Pub 2017. PMID: 28482717.
107. Gunther JR, Rahman AR, Dong W, Yehia ZA, Kebriaei P, Rondon G, Pinnix CC, Milgrom SA, Allen PK, Dabaja BS, Smith GL. Craniospinal Irradiation Prior to Stem Cell Transplant for Hematologic Malignancies with CNS Involvement: Effectiveness and Toxicity after Photon or Proton Treatment. Pract Radiat Oncol 7(6):e401-e408, 2017. e-Pub 2017. PMID: 28666906.
108. Wang H, Milgrom SA, Dabaja BS, Smith GL, Martel M, Pinnix CC. Daily CT guidance improves target coverage during definitive radiation therapy for gastric MALT lymphoma. Pract Radiat Oncol 7(6):e471-e478, 2017. e-Pub 2017. PMID: 28377138.
109. Milgrom SA, Pinnix CC, Chuang H, Oki Y, Akhtari M, Mawlawi O, Garg N, Gunther JR, Reddy JP, Smith GL, Rohren E, Hagemeister FB, Lee HJ, Fayad LE, Dong W, Osborne EM, Abou Yehia Z, Fanale M, Dabaja BS. Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?. Br J Haematol 179(3):488-496, 2017. e-Pub 2017. PMID: 28832956.
110. Lewis DJ, Vin H, Hinojosa T, Tetzlaff MT, Dabaja BS, Duvic M. Primary Cutaneous Peripheral T-Cell Lymphoma in a Sporotrichoid Pattern: A Case Report. J Cutan Med Surg 21(6):568-571, 2017. e-Pub 2017. PMID: 28712310.
111. Li X, Xu-Monette ZY, Yi S, Dabaja BS, Manyam GC, Westin J, Fowler N, Miranda RN, Zhang M, Ferry JA, Medeiros LJ, Harris NL, Young KH. Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived from Centrocytes in the Germinal Center. Am J Surg Pathol 41(10):1309-1321, 2017. e-Pub 2017. PMID: 28817403.
112. Rechner LA, Maraldo MV, Vogelius IR, Zhu XR, Dabaja BS, Brodin NP, Petersen PM, Specht L, Aznar MC. Life years lost attributable to late effects after radiotherapy for early-stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold. Radiother Oncol 125(1):41-47, 2017. e-Pub 2017. PMID: 28838605.
113. Jabbour E, Guastad Daver N, Short NJ, Huang X, Chen HC, Maiti A, Ravandi F, Cortes J, Abi Aad S, Garcia-Manero G, Estrov Z, Kadia T, O'Brien S, Dabaja B, Bueso-Ramos C, Strati P, Bivins C, Pierce S, Kantarjian H. Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia. Am J Hematol 92(9):924-928, 2017. e-Pub 2017. PMID: 28556489.
114. Jain P, Milgrom SA, Patel KP, Nastoupil L, Fayad L, Wang M, Pinnix CC, Dabaja BS, Smith GL, Yu J, Hu S, Bueso Ramos CE, Kanagal-Shamanna R, Medeiros LJ, Oki Y, Fowler N. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. Br J Haematol 178(3):403-412, 2017. e-Pub 2017. PMID: 28382648.
115. Fanale MA, Cheah CY, Rich A, Medeiros LJ, Lai CM, Oki Y, Romaguera JE, Fayad LE, Hagemeister FB, Samaniego F, Rodriguez MA, Neelapu SS, Lee HJ, Nastoupil L, Fowler NH, Turturro F, Westin JR, Wang ML, McLaughlin P, Pinnix CC, Milgrom SA, Dabaja B, Horowitz SB, Younes A. Encouraging activity for R-CHOP in advanced stage nodular lymphocyte predominant Hodgkin lymphoma. Blood 130(4):472-477, 2017. e-Pub 2017. PMID: 28522441.
116. Smith GL, Duvic M, Yehia ZA, Allen P, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Khoury JD, Dabaja BS. Effectiveness of Low-dose Radiation for Primary Cutaneous Anaplastic Large Cell Lymphoma. Adv Radiat Oncol 2(3):363-369, 2017. e-Pub 2017. PMID: 29114604.
117. Pinnix CC, Andraos TY, Dabaja B, Milgrom S, Smith G, Chihara D, Ng A, Fayad LE, Oki Y, Neelapu S, Westin J, Rodriguez MA, Nastoupil LJ. Diffuse large B-cell lymphoma in very elderly patients over 80 years old: incorporating consolidative radiation therapy into management decisions. Adv Radiat Oncol 2(3):370-380, 2017. e-Pub 2017. PMID: 29114605.
118. Kim EJ, Lewis DJ, Dabaja BS, Duvic M. Curcumin for the Treatment of Tumor-Stage Mycosis Fungoides. Dermatol Ther 30(4), 2017. e-Pub 2017. PMID: 28585397.
119. Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head Neck 39(6):1095-1100, 2017. e-Pub 2017. PMID: 28370694.
120. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Smith M, Winter JN, Yahalom J, Burns J, Ogba N, Sundar H. Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15(5):608-638, 2017. e-Pub 2017. PMID: 28476741.
121. Milgrom SA, Jauhari S, Plastaras JP, Nieto Y, Dabaja BS, Pinnix CC, Smith GL, Allen PK, Lukens JN, Maity A, Oki Y, Fanale MA, Nasta SD. A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation. Cancer 123(8):1363-1371, 2017. e-Pub 2017. PMID: 27984652.
122. Wieser I, Huean A, Bush AE, Dabaja BS, Duvic M. Periorbital involvement in early-stage mycosis fungoides. Acta Derm Venereol 97(8):976-978, 2017. e-Pub 2017. PMID: 28421231.
123. Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, Rohren E, Garg N, Chuang H, Yehia ZA, Reddy JP, Gunther JR, Khoury JD, Suki T, Osborne EM, Oki Y, Fanale M, Dabaja BS. Chemotherapy response assessment by FDG-PET-CT in early-stage classical hodgkin lymphoma: Moving beyond the five-point deauville score. Int J Radiat Oncol Biol Phys 97(2):333-338, 2017. e-Pub 2017. PMID: 28068241.
124. Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. Am J Hematol 92(2):115-160, 2017. e-Pub 2017. PMID: 27874212.
125. Zhou R, Liao Z, Pan T, Milgrom SA, Pinnix CC, Shi A, Tang L, Yang J, Liu Y, Gomez D, Nguyen QN, Dabaja BS, Court L, Yang J. Cardiac atlas development and validation for automatic segmentation of cardiac substructures. Radiother Oncol 122(1):66-71, 2017. e-Pub 2017. PMID: 27939201.
126. Brammer JE, Chihara D, Poon LM, Caimi P, de Lima M, Ledesma C, Rondon G, Ciurea SO, Nieto Y, Fanale M, Dabaja B, Maziarz RT, Champlin RE, Hosing C, Oki Y. Management of Advanced and Relapsed/Refractory Extra-Nodal Natural Killer T-Cell Lymphoma (ENKL): An Analysis of Stem Cell Transplant and Chemotherapy Outcomes. Clinical Lymphoma, Myeloma & Leukemia 18(1):e41-50, 2017. e-Pub 2017.
127. Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS. Dorsal Column Myelopathy after Intrathecal Chemotherapy for Leukemia: Intratkhecal Chemotherapy Myelopathy. Am J Hematol 92:155-160, 2017. e-Pub 2017.
128. Dabaja B. Renaissance of low-dose radiotherapy concepts for cutaneous lymphomas. Oncol Res Treat 40(5):255-260, 2017. e-Pub 2017. PMID: 28380490.
129. Jain P, Milgram SA, Patel KP, Nastoupil L, Fayad L, Wang M, Pinnix C, bDabaja BS, Smith GL, Yu J, Sh H, Buso Ramos CE, Kanagal-Shamanna R, Medeiros LJ, Oki Y, Fowler N. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. British Journal of Haematology 178:403-412, 2017. e-Pub 2017.
130. Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, Rohren E, Garg N, Chuang H, Yehia ZA, Reddy JP, Gunther JR, Khoury JD, Suki T, Osborne EM, Oki Y, Fanale M, Dabaja BS. Chemotherapy Response Assessment by FDG-PET-CT in Early-Stage Classical Hodgkin Lymphoma: Moving Beyond the 5-Point Deauville Score. Int J Radiat Oncol Biol Phys 97(2):333-338, 2017. e-Pub 2017.
131. Dabaja BS, Zelenetz AD, Ng AK, Tsang RW, Qi S, Allen PK, Hodgson D, Ricardi U, Hoppe RT, Advani R, Mauch PM, Constine LS, Specht L, Li Y, Terezakis SA, Wirth A, Reinartz G, Eich HT, Aleman BMP, Barr P, Yahalom J. Early-stage mantle cell lymphoma: A retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG). Annals of Oncology:2185-2190, 2017. e-Pub 2017.
132. Abou Yehia Z, Mikhaeel GN, Smith G, Pinnix CC, Milgrom SA, Tang C, Jiang W, Fanale MA, Oki Y, Shank JH, Horace T, Reddy J, Akhtari M, Gunther JR, Suki T, Allen PK, Turner S, Mawlawi O, Dabaja BS. Does bleomycin lung toxicity increase the risk of radiation pneumonitis in hodgkin lymphoma?. Int J Radiat Oncol Biol Phys 96(5):951-958, 2016. e-Pub 2016. PMID: 27742539.
133. Dhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS, Radiation Oncology–Lymphoma EPO. ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. Am J Clin Oncol 39(6):535-544, 2016. e-Pub 2016. PMID: 27643717.
134. Milgrom SA, Cheah CY, Pinnix CC, Smith GL, Dabaja BS, Horace P, Chevez-Barrios P, Fowler NH, Gombos DS. Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma. Leuk Lymphoma 57(11):1-7, 2016. e-Pub 2016. PMID: 27075636.
135. Wirth A, Dabaja B. Optimizing treatment for nasal NK T-cell lymphoma. Leuk Lymphoma 57(11):2487-8, 2016. e-Pub 2016. PMID: 27676422.
136. Nieto Y, Valdez BC, Thall PF, Jones RB, Wei W, Myers A, Hosing C, Ahmed S, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Shah N, Bashir Q, Alousi A, Oki Y, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS. Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma: HDC for Refractory Lymphoma. Cancer 122(17):2680-8, 2016. e-Pub 2016. PMID: 27203405.
137. Cheah CY, Bröckelmann PJ, Chihara D, Moskowitz AJ, Engert A, Jerkeman M, El-Galaly TC, Augustson B, Vose J, Bartlett NL, Villa D, Connors JM, Feldman T, Pinnix CC, Milgrom SA, Dabaja B, Oki Y, Fanale MA. Clinical characteristics and outcomes of patients with hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration: CNS involvement in Hodgkin Lymphoma. Am J Hematol 91(9):894-9, 2016. e-Pub 2016. PMID: 27222367.
138. Pinnix CC, Osborne EM, Chihara D, Lai P, Zhou S, Ramirez MM, Oki Y, Hagemeister FB, Rodriguez AM, Samaniego F, Fowler N, Romaguera JE, Turturro F, Fayad L, Westin JR, Nastoupil L, Neelapu SS, Cheah CY, Dabaja BS, Milgrom SA, Smith GL, Horace P, Milbourne A, Wogan CF, Ballas L, Fanale MA. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy. JAMA Oncol 2(8):1065-9, 2016. e-Pub 2016. PMID: 27227654.
139. Million L, Yi EJ, Wu F, Von Eyben R, Campbell BA, Dabaja B, Tsang RW, Ng A, Wilson LD, Ricardi U, Kirova Y, Hoppe RT. Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group (ILROG) Multi-Institutional Experience. Int J Radiat Oncol Biol Phys 95(5):1454-1459, 2016. e-Pub 2016. PMID: 27315663.
140. Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS, Radiation OncologyLymphoma EPO. ACR Appropriateness Criteria Hodgkin Lymphoma-Unfavorable Clinical Stage I and II. Am J Clin Oncol 39(4):384-95, 2016. e-Pub 2016. PMID: 27299425.
141. Haque W, Dabaja B, Tann A, Khan M, Szeja S, Butler EB, Teh BS. Changes in Treatment Patterns and Impact of Radiotherapy for Early Stage Diffuse Large B Cell Lymphoma after Rituximab: A Population- Based Analysis. Radiother Oncol 120(1):150-5, 2016. e-Pub 2016. PMID: 27373911.
142. Ng AK, Dabaja BS, Hoppe RT, Illidge T, Yahalom J. Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era. J Clin Oncol 34(13):1443-7, 2016. e-Pub 2016. PMID: 26903576.
143. Dabaja BS, Mikhaeel NG. In the Battle Between Protons and Photons for Hematologic Malignancies, the Patient Must Win. Int J Radiat Oncol Biol Phys 95(1):43-5, 2016. e-Pub 2016. PMID: 27084623.
144. Cheah CY, Milgrom S, Chihara D, Gombos DS, Pinnix CC, Dabaja BS, Fowler NH. Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. Neuro Oncol 18(4):575-81, 2016. e-Pub 2016. PMID: 26487691.
145. Kim MM, Dabaja BS, Medeiros J, Kim S, Allen P, Chevez-Barrios P, Gombos DS, Fowler N. Survival outcomes of primary intraocular lymphoma: A single-institution experience. Am J Clin Oncol 39(2):109-13, 2016. e-Pub 2016. PMID: 24390272.
146. Pinnix CC, Shah JJ, Chuang H, Costelloe CM, Medeiros LJ, Wogan CF, Reed V, Smith GL, Milgrom S, Patel K, Huo J, Turturro F, Romaguera J, Fayad L, Oki Y, Fanale MA, Westin J, Nastoupil L, Hagemeister FB, Rodriguez A, Qazilbash M, Shah N, Bashir Q, Ahmed S, Nieto Y, Hosing C, Rohren E, Dabaja B. Doxorubicin-based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. Clin Lymphoma Myeloma Leuk 16(3):122-8, 2016. e-Pub 2016. PMID: 26795083.
147. Talpur R, Sui D, Gangar P, Dabaja BS, Duvic M. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides. Clin Lymphoma Myeloma Leuk 16(1):49-56, 2016. e-Pub 2016. PMID: 26702474.
148. Talpur R, Sui D, Ganger P, Dabaja BS, Duvic M. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides. Clinical Lymphoma, Myeloma & Leukemia 16(1):49-56, 2016. e-Pub 2016.
149. Gunther JR, Fanale MA, Reddy JP, Akhtari M, Smith GL, Pinnix CC, Milgrom SA, Yehia ZA, Allen PK, Osborne EM, Mawlawi O, Dabaja BS. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy with Radiation. Int J Radiat Oncol Biol Phys 96(1):110-118, 2016. e-Pub 2016.
150. Gunther JR, Fanale MA, Reddy JP, Akhtari M, Smith GL, Pinnix CC, Milgrom SA, Yehia ZA, Allen PK, Osborne EM, Mawlawi O, Dabaja BS. Treatment of early-stage unfavorable Hodgkin lymphoma: Efficacy and toxicity of 4 vs. 6 cycles of ABVD chemotherapy with radiation. Int J Radiat Oncol Biol Phys 96(1):110-118, 2016. e-Pub 2016.
151. Haque W, Dabaja B, Tann A, Khan M, Szeja S, Bulter EB, Teh BS. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis. Radiother Oncol 120(1):150-155, 2016. e-Pub 2016.
152. Akhtari M, Reddy JP, Pinnix CC, Allen PK, Osborne EM, Gunther JR, Milgrom SA, Smith GL, Wogan CF, Fowler N, Rodriguez MA, Dabaja B. Primary cutaneous B-cell lymphoma (Non-Leg Type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma 57(1):1-13, 2016. e-Pub 2016. PMID: 25860237.
153. Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, Champlin R, Duvic M. Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. Ann Oncol 26(12):2490-5, 2015. e-Pub 2015. PMID: 26416896.
154. Brown DN, Wieser I, Wang C, Dabaja BS, Duvic M. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature. J Am Acad Dermatol 73(6):976-86, 2015. e-Pub 2015. PMID: 26476898.
155. Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. Am J Clin Oncol 38(6):610-20, 2015. e-Pub 2015. PMID: 26583344.
156. Xu-Monette ZY, Dabaja BS, Wang X, Tu M, Manyam GC, Tzankov A, Xia Y, Zhang L, Sun R, Visco C, Dybkaer K, Yin L, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Parsons BM, Zhao X, Winter JN, Piris MA, McDonnell TJ, Miranda RN, Li Y, Medeiros LJ, Young KH. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol 28(12):1555-73, 2015. e-Pub 2015. PMID: 26541272.
157. Reddy JP, Akhtari M, Smith GL, Pinnix C, Osborne EM, Gunther JR, Allen PK, Yehia ZA, Fanale M, Rodriguez MA, Fowler N, Milgrom SA, Wogan CF, Dabaja BS. Outcomes after Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma with Bulky Disease. Clin Lymphoma Myeloma Leuk 15(11):664-670.e2, 2015. e-Pub 2015. PMID: 26321471.
158. Nieto Y, Valdez BC, Thall PF, Ahmed S, Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Alousi A, Shah N, Bashir Q, Liu Y, Oki Y, Hagemeister F, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS. Vorinostat Combined with High-Dose Gemcitabine, Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphomas. Biol Blood Marrow Transplant 21(11):1914-20, 2015. e-Pub 2015. PMID: 26071868.
159. Youssef B, Shank J, Reddy JP, Pinnix CC, Farha G, Akhtari M, Allen PK, Fanale MA, Garcia JA, Horace PH, Milgrom S, Smith GL, Nieto Y, Arzu I, Wang H, Fowler N, Rodriguez MA, Dabaja B. Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma. Radiat Oncol 10(1):206, 2015. e-Pub 2015. PMID: 26407853.
160. Wang C, Reusser N, Shelton M, Reed J, Doan H, Torres-Cabala CA, Dabaja B, Duvic M. An unusual case of cytotoxic peripheral T-cell lymphoma. JAAD Case Rep 1(5):257-60, 2015. e-Pub 2015. PMID: 27051746.
161. Zhou R, Yang J, Pan T, Milgrom S, Pinnix C, Shi A, Yang J, Liu Y, Nguyen Q, Gomez D, Dabaja B, Balter P, Court L, Liao Z. SU-E-J-129: Atlas Development for Cardiac Automatic Contouring Using Multi-Atlas Segmentation. Med Phys 42(6):3294, 2015. e-Pub 2015.
162. Tao R, Allen PK, Rodriguez A, Shihadeh F, Pinnix CC, Arzu I, Reed VK, Oki Y, Westin JR, Fayad LE, Medeiros LJ, Dabaja B. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys 92(1):122-9, 2015. e-Pub 2015. PMID: 25754633.
163. Polansky M, Talpur R, Daulat S, Hosing C, Dabaja B, Duvic M. Long-term complete responses to combination therapies and allogeneic stem cell transplants in patients with Sézary syndrome. Clin Lymphoma Myeloma Leuk 15(5):83-93, 2015. e-Pub 2015. PMID: 25458083.
164. Pinnix CC, Smith GL, Milgrom S, Osborne EM, Reddy JP, Akhtari M, Reed V, Arzu I, Allen PK, Wogan CF, Fanale MA, Oki Y, Turturro F, Romaguera J, Fayad L, Fowler N, Westin J, Nastoupil L, Hagemeister FB, Rodriguez MA, Ahmed S, Nieto Y, Dabaja B. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for hodgkin and non-hodgkin lymphoma. Int J Radiat Oncol Biol Phys 92(1):175-82, 2015. e-Pub 2015. PMID: 25863764.
165. Maraldo MV, Dabaja BS, Filippi AR, Illidge T, Tsang R, Ricardi U, Petersen PM, Schut DA, Garcia J, Headley J, Parent A, Guibord B, Ragona R, Specht L. Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92(1):144-152, 2015. e-Pub 2015. PMID: 25670544.
166. Pinnix CC, Dabaja B, Ahmed MA, Chuang HH, Costelloe C, Wogan CF, Reed V, Romaguera JE, Neelapu S, Oki Y, Rodriguez MA, Fayad L, Hagemeister FB, Nastoupil L, Turturro F, Fowler N, Fanale MA, Nieto Y, Khouri IF, Ahmed S, Medeiros LJ, Davis RE, Westin J. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by (18)fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 92(1):113-21, 2015. e-Pub 2015. PMID: 25863759.
167. Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network Lymphoma Outcomes Project. Cancer 121(7):1032-1039, 2015. e-Pub 2015. PMID: 25492236.
168. Hoppe RT, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, Million L, Dabaja B, Gangar P, Duvic M, Kim YH. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from three phase II clinical trials. J Am Acad Dermatol 72(2):286-92, 2015. e-Pub 2015. PMID: 25476993.
169. Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA Karen M, Winkfield KM, Constine SL. Hodgkin Lymphoma-Unfavorable Clinical Stage I and II. American College of Radiology, 2015. e-Pub 2015.
170. Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, Champlin R, Duvic M. Allogeneic Stem Cell Transplantation in Patients with Cutaneous Lymphoma: Updated Results from a Single Institution. Annals of Oncology 26:2490-2495, 2015. e-Pub 2015.
171. Hoppe RT, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, Million L, Dabaja B, Gangar P, Duvic M, Kim YH. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials. J American Academy of Dermatology 72(2):286-292, 2015. e-Pub 2015.
172. Polansky M, Talpur R, Daulat S, Hosing C, Dabaja B, Duvic M. Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients with Sézary Syndrome. Clinical Lymphoma, Myeloma & Leukemia 15(5):e83-e93, 2015. e-Pub 2015.
173. Youssef B, Shank J, Reddy JP, Pinnix CC, Farha G, Akhtari M, Allen PK, Fanale MA, Garcia JA, Horace PH, Milgrom S, Smith GL, Nieto Y, Arzu I, Wang H, Fowler N, Rodriguez MA, Dabaja B. Incidence and predictors of Lhermitte’s sign among patients receiving mediastinal radiation for lymphoma. Radiation Oncology 10:206, 2015. e-Pub 2015.
174. Haque W, Voong KR, Shihadeh F, Arzu I, Pinnix C, Mazloom A, Medeiros LJ, Romaguera J, Rodriguez A, Wang M, Allen P, Dabaja B. Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients. Clin Lymphoma Myeloma Leuk 14(6):474-479, 2014. e-Pub 2014. PMID: 25108680.
175. Walker GV, Shihadeh F, Kantarjian H, Allen P, Rondon G, Kebriaei P, O'Brien S, Kedir A, Said M, Grant JD, Thomas DA, Gidley PW, Arzu I, Pinnix C, Reed V, Dabaja BS. Comprehensive craniospinal radiation for controlling central nervous system leukemia. Int J Radiat Oncol Biol Phys 90(5):1119-1125, 2014. e-Pub 2014. PMID: 25539370.
176. Hamdi A, Mawad R, Bassett R, di Stasi A, Ferro R, Afrough A, Ram R, Dabaja B, Rondon G, Champlin R, Sandmaier BM, Doney K, Bar M, Kebriaei P. Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(11):1767-1771, 2014. e-Pub 2014. PMID: 25017763.
177. Ha CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria: follow-up of Hodgkin lymphoma. J Am Coll Radiol 11(11):1026-1033.e3, 2014. e-Pub 2014. PMID: 25278496.
178. Oki Y, Noorani M, Lin P, Davis RE, Neelapu SS, Ma L, Ahmed M, Rodriguez MA, Hagemeister FB, Fowler N, Wang M, Fanale MA, Nastoupil L, Samaniego F, Lee HJ, Dabaja BS, Pinnix CC, Medeiros LJ, Nieto Y, Khouri I, Kwak LW, Turturro F, Romaguera JE, Fayad LE, Westin JR. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol 166(6):891-901, 2014. e-Pub 2014. PMID: 24943107.
179. Dabaja BS, Hess K, Shihadeh F, Podoloff DA, Medeiros LJ, Mawlawi O, Arzu I, Oki Y, Hagemeister FB, Fayad LE, Reed VK, Kedir A, Wogan CF, Rodriguez A. Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation. Int J Radiat Oncol Biol Phys 89(2):384-391, 2014. e-Pub 2014. PMID: 24721592.
180. Oki Y, Chuang H, Chasen B, Jessop A, Pan T, Fanale M, Dabaja B, Fowler N, Romaguera J, Fayad L, Hagemeister F, Rodriguez MA, Neelapu S, Samaniego F, Kwak L, Younes A. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Br J Haematol 165(1):112-116, 2014. e-Pub 2014. PMID: 24386943.
181. Voong KR, McSpadden K, Pinnix CC, Shihadeh F, Reed V, Salehpour MR, Arzu I, Wang H, Hodgson D, Garcia J, Aristophanous M, Dabaja BS. Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma. Radiat Oncol 9(1):94, 2014. e-Pub 2014. PMID: 24735767.
182. Aristophanous M, Chi P, Tung S, Pinnix C, Dabaja B. SU-E-T-522: A Multi-Isocenter VMAT Technique for Cranio-Spinal Irradiation. Medical Physics 41(6):347, 2014. e-Pub 2014.
183. Chi P, Pinnix C, Dabaja B, Wang C, Aristophanous M, Tung S. SU-E-T-404: Simple Field-In-Field Technique for Total Body Irradiation in Large Patients. Medical Physics 41(6):318, 2014. e-Pub 2014.
184. Dabaja BS, Phan J, Mawlawi O, Medeiros LJ, Etzel C, Liang FW, Podoloff D, Oki Y, Hagemeister FB, Chuang H, Fayad LE, Westin JR, Shihadeh F, Allen PK, Wogan CF, Rodriguez MA. Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma. Leuk Lymphoma 54(12):2631-2638, 2013. e-Pub 2013. PMID: 23488661.
185. Wang CM, Duvic M, Dabaja BS. Acral erosive mycosis fungoides: successful treatment with localised radiotherapy. BMJ Case Rep 2013, 2013. e-Pub 2013. PMID: 23595169.
186. Jain P, Sargent R, Castle KO, Benjamini O, Konoplev S, Dabaja BS, Kadia T. Multiple recurrent extra-medullary relapses of high grade diffuse large B cell lymphoma presenting in leukemic phase. Am J Hematol 88(5):433-434, 2013. e-Pub 2013. PMID: 23460270.
187. Wang H, Tung S, Wang C, Mahajan A, Dabaja B, Martel M. SU-E-T-592: Investigation of Volumetric Modulated Arc Therapy for Total Body Irradiation with Lung Blocks. Medical Physics 40(6):341, 2013. e-Pub 2013.
188. Pinnix CC, Reed V, Dabaja B. Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune disease. J Natl Compr Canc Netw 10(7):815-819, 2012. e-Pub 2012. PMID: 22773797.
189. Sharp H, Grosshans D, Kadia T, Dabaja BS. Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemia. BMJ Case Rep 2012, 2012. e-Pub 2012. PMID: 22787181.
190. Younes A, Oki Y, McLaughlin P, Copeland AR, Goy A, Pro B, Feng L, Yuan Y, Chuang HH, Macapinlac HA, Hagemeister F, Romaguera J, Samaniego F, Fanale MA, Dabaja BS, Rodriguez MA, Dang N, Kwak LW, Neelapu SS, Fayad LE. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. Blood 119(18):4123-4128, 2012. e-Pub 2012. PMID: 22371887.
191. Batty N, Hagemeister FB, Feng L, Romaguera JE, Rodriguez MA, McLaughlin P, Samaniego F, Copeland A, Dabaja BS, Younes A. Doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy with interferon for advanced stage classic hodgkin's lymphoma: a 10-year follow-up study. Leuk Lymphoma 53(5):801-806, 2012. e-Pub 2012. PMID: 22023528.
192. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H, Cancer Network NC. Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Canc Netw 10(5):589-597, 2012. e-Pub 2012. PMID: 22570290.
193. Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M, Kantarjian H, Allen P, Ballas L, Pierce S, Dabaja B. Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer 118(1):112-117, 2012. e-Pub 2012. PMID: 21692072.
194. Dabaja B, Wang Z, Stovall M, Baker JS, Smith SA, Khan M, Ballas L, Salehpour MR. Involved field radiation for Hodgkin's lymphoma: The actual dose to breasts in close proximity. Med Dosim 37(4):374-382, 2012. e-Pub 2012. PMID: 22513213.
195. Reed V, Shah J, Medeiros LJ, Ha CS, Mazloom A, Weber DM, Arzu IY, Orlowski RZ, Thomas SK, Shihadeh F, Alexanian R, Dabaja BS. Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy. Cancer 117(19):4468-4474, 2011. e-Pub 2011. PMID: 21437886.
196. Phan J, Mazloom A, Abboud M, Salehpour M, Reed V, Zreik T, Shihadeh F, Fisher C, Wogan C, Dabaja B. Consolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapy. Am J Clin Oncol 34(5):499-505, 2011. e-Pub 2011. PMID: 21537149.
197. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom J, Lymphoma NH. Hodgkin lymphoma. J Natl Compr Canc Netw 9(9):1020-1058, 2011. e-Pub 2011. PMID: 21917626.
198. Li J, Dabaja B, Reed V, Allen PK, Cai H, Amin MV, Garcia JA, Cox JD. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys 81(1):167-174, 2011. e-Pub 2011. PMID: 20643518.
199. Mazloom A, Rodriguez A, Ha CS, Medeiros LJ, Wogan C, Shihadeh F, Allen P, Fowler N, Dabaja B. Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphoma. Cancer 117(11):2461-6, 2011. e-Pub 2011. PMID: 24048794.
200. Dabaja BS, Rebueno NC, Mazloom A, Thorne S, Perrin KJ, Tolani N, Das P, Delclos ME, Iyengar P, Reed VK, Horace P, Salehpour MR. Radiation for Hodgkin's lymphoma in young female patients: A new technique to avoid the breasts and decrease the dose to the heart. Int J Radiat Oncol Biol Phys 79(2):503-507, 2011. e-Pub 2011. PMID: 20418023.
201. Dabaja B, Perrin KJ, Romaguera JE, Horace P, Wogan CF, Shihadeh F, Salehpour MR. Successful treatment of a free-moving abdominal mass with radiation therapy guided by cone-beam computed tomography: A case report. J Med Case Rep 4:329, 2010. e-Pub 2010. PMID: 20958963.
202. Mazloom A, Medeiros LJ, McLaughlin PW, Reed V, Cabanillas FF, Fayad LE, Pro B, Gonzalez G, Iyengar P, Urbauer DL, Dabaja BS. Marginal zone lymphomas: Factors that affect the final outcome. Cancer 116(18):4291-4298, 2010. e-Pub 2010. PMID: 20549822.
203. Phan J, Mazloom A, Medeiros LJ, Zreik TG, Wogan C, Shihadeh F, Rodriguez MA, Fayad L, Fowler N, Reed V, Horace P, Dabaja BS. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 28(27):4170-4176, 2010. e-Pub 2010. PMID: 20713859.
204. Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B. Hodgkin lymphoma involving extranodal and nodal head and neck sites: Characteristics and outcomes. Cancer 116(16):3825-3829, 2010. e-Pub 2010. PMID: 20564093.
205. Mazloom A, Fowler N, Medeiros LJ, Iyengar P, Horace P, Dabaja BS. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: The MD Anderson Cancer Center experience. Leuk Lymphoma 51(7):1217-1224, 2010. e-Pub 2010. PMID: 20443676.
206. Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, Acholonu S, Khouri I, Champlin R, Hosing C. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol 28(14):2365-2372, 2010. e-Pub 2010. PMID: 20351328.
207. Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM, Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD, Cancer Network NC. Hodgkin disease/lymphoma. J Natl Compr Canc Netw 6(6):594-622, 2008. e-Pub 2008. PMID: 18597713.
208. Ha CS, Kong JS, Dabaja BS, Fayad LE, Hess MA, Kim EE, Podoloff DA, Cabanillas F, Cox JD, Macapinlac HA. How often does 18f-FDG PET scan change management during treatment of Hodgkin lymphoma (HL)?. Int J Radiat Oncol Biol Phys 69(3), 2007. e-Pub 2007.
209. Geara FB, Nasr E, Tucker SL, Charafeddine M, Dabaja B, Eid T, Abbas J, Salem Z, Shamseddine A, Issa P, El Saghir N. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: Influence of clinical presentation on outcome. Int J Radiat Oncol Biol Phys 68(2):364-369, 2007. e-Pub 2007. PMID: 17324529.
210. Dabaja B, Cox JD, Buchholz TA. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. J Clin Oncol 25(1):3-5, 2007. e-Pub 2007. PMID: 17194900.
211. Dabaja B, Salehpour MR, Rosen I, Tung S, Morrison WH, Ang KK, Garden AS. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 63(4):1000-1005, 2005. e-Pub 2005. PMID: 15978743.
212. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: Presentation, prognostic factors, and outcome of 217 patients. Cancer 101(3):518-526, 2004. e-Pub 2004. PMID: 15274064.
213. Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Cancer 98(5):1021-1028, 2003. e-Pub 2003. PMID: 12942571.
214. Dabaja BS, Ha CS, Wilder RB, Pro B, McLaughlin P, Cabanillas F, Cox JD. Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer J 9(4):321-324, 2003. e-Pub 2003. PMID: 12967143.
215. Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 94(10):2738-2744, 2002. e-Pub 2002. PMID: 12173345.
216. Dabaja BS, O'Brien SM, Kantarjian HM, Cortes JE, Thomas DA, Albitar M, Schlette ES, Faderl S, Sarris A, Keating MJ, Giles FJ. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. Leuk Lymphoma 42(3):329-337, 2001. e-Pub 2001. PMID: 11699397.
217. Shamseddine AI, Taher A, Dabaja B, Dandashi A, Salem Z, El Saghir NS. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer. Am J Clin Oncol 22(3):298-302, 1999. e-Pub 1999. PMID: 10362341.
218. Dabaja BS, Faderl S, Thomas D, Cortes J, O'Brien S, Nasr F, Pierce S, Hayes K, Glassman A, Keating M, Kantarjian HM. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications. Leukemia 13(6):869-872, 1999. e-Pub 1999. PMID: 10360374.
219. Liang FW, Chan W, Swartz M, Dabaja B, Etzel C. Joint modeling of a mixture time-to-event variable with its discrete and continuous mixture covariates. Stat Med.
220. Chockalingam R, Dabaja BS, Madeleine D. Indolent CD8-positive Lymphoid Proliferation of the Foot: a case report. Clin Lymphoma Myeloma Leuk.

Invited Articles

1. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H, cancer network NC. Hodgkin lymphoma, version 2.2015. J Natl Compr Canc Netw 13(5):554-86, 2015. e-Pub 2015. PMID: 25964641.

Other Articles

1. Campbell, BA, Prince, HM, Thursky, K, Dabaja, BS, Hoppe, RT, Specht, L, Morris, S, Porceddu, SV Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma. Seminars in radiation oncology 35(1):110-125, 2025. PMID: 39672636.
2. Kahn J, Dabaja B, Wu S, Kelly K, Berkahn L, Pavlovsky A, Sureda A, LaCasce A Classic Hodgkin lymphoma. Hematol Oncol 42(6), 2024. PMID: 38037872.
3. Damron EP, Qazilbash MH, Fang PQ, Wu SY, Dabaja BS, Rondon G, Hosing C, Champlin RE, Bashir Q, Shpall EJ, Knafl MK, Lee HC, Manasanch EE, Patel K, Thomas SK, Orlowski RZ, Weber DM, Pinnix CC, Gunther JR Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. Transplant Cell Ther 29(1):37.e1-37.e7, 2023. PMID: 37753818.
4. Dabaja B, Spiotto M Radiation for hematologic malignancies: from cell killing to immune cell priming. Front Oncol 13:1205836, 2023. PMID: 37384297.
5. Wu SY, Short NJ, Nasr L, Dabaja BS, Fang PQ Central Nervous System Prophylaxis and Treatment in Acute Leukemias. Curr Treat Options Oncol 23(12):1829-1844, 2022. PMID: 36510037.
6. Lyapichev KA, Medeiros LJ, Ivashkevich Y, Thakral B, Dabaja BS, Lin P, Iqbal F, Konoplev S MALT lymphoma of the tongue: An unusual site that may present a diagnostic challenge. Ann Diagn Pathol 56:151841, 2022. PMID: 34717192.
7. Hoppe BS, Advani R, Milgrom SA, Bakst RL, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Mansur DB, Metzger ML, Pinnix CC, Plastaras JP, Roberts KB, Smith SM, Terezakis SA, Kirwan JM, Constine LS Primary Mediastinal B-cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium SocietyTM Appropriate Use Criteria. Int J Radiat Oncol Biol Phys 111(1):36-44, 2021. PMID: 33774076.
8. Qi, S, Milgrom, SA, Dabaja, BS Erratum. Blood Advances 5(13):2793, 2021. PMID: 34255032.
9. Fang PQ, Gunther JR, Wu SY, Dabaja BS, Nastoupil LJ, Ahmed S, Neelapu SS, Pinnix CC Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy. Front Oncol 11:648655, 2021. PMID: 33842363.
10. Lyapichev KA, Ivashkevich Y, Chernov Y, Chinenov D, Shpot E, Bessonov AA, Dabaja BS, Konoplev S MALT Lymphoma of the Urinary Bladder Shows a Dramatic Female Predominance, Uneven Geographic Distribution, and Possible Infectious Etiology. Res Rep Urol 13:49-62, 2021. PMID: 33575225.
11. Paul S, Rausch CR, Jain N, Kadia T, Ravandi F, DiNardo CD, Welch MA, Dabaja BS, Daver N, Garcia-Manero G, Wierda W, Pemmaraju N, Montalban Bravo G, Thompson P, Verstovsek S, Konopleva M, Kantarjian H, Jabbour E Treating Leukemia in the Time of COVID-19. Acta Haematol 144(2):1-13, 2021. PMID: 32392559.
12. Kim EJ, Aria AB, Wilmas K, Lewis DJ, Torres-Cabala CA, Nunez C, Dabaja BS, Duvic M Primary Cutaneous CD4+ Small- to Medium-sized Pleomorphic T-cell Lymphoproliferative Disorder in a Pediatric Patient Successfully Treated with Low-dose Radiation. Pediatr Dermatol 36(1):e23-e26, 2019. PMID: 30548331.
13. Dabaja BS, Specht L, Yahalom J Lymphoblastic Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 102(3):508-514, 2018. PMID: 30238900.
14. Bakst RL, Dabaja BS, Specht LK, Yahalom J Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 102(2):314-319, 2018. PMID: 30191865.
15. Dabaja BS Successful role of radiation therapy: Account for every single gray and make every single gray count. Best Pract Res Clin Haematol 31(3):217-232, 2018. PMID: 30213391.
16. Pinnix CC, Yahalom J, Specht L, Dabaja BS Radiation in Central Nervous System Leukemia: Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 102(1):53-58, 2018. PMID: 30102203.
17. Wong JYC, Filippi AR, Dabaja BS, Yahalom J, Specht L Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 101(3):521-529, 2018. PMID: 29893272.
18. Winkfield KM, Advani RH, Ballas LK, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Younes A, Constine LS ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma. Oncology (Williston Park) 30(12):1099-103, 1106-8, 2016. PMID: 27987203.
19. Ahmed M, Li L, Pinnix C, Dabaja B, Nomie K, Lam L, Wang M ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma. Crit Rev Oncol Hematol 107:14-19, 2016. PMID: 27823642.
20. Milgrom SA, Nieto Y, Pinnix CC, Smith GL, Wogan CF, Rondon G, Medeiros LJ, Kebriaei P, Dabaja BS Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: Two case reports. J Med Case Rep 10:209, 2016. PMID: 27465468.
21. Specht L, Dabaja B, Illidge T, Wilson LD, Hoppe RT, Oncology Group ILR Modern radiation therapy for primary cutaneous lymphomas - field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 92(1):32-39, 2015. PMID: 25863751.
22. Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, Dabaja B, Dharmarajan K, Ng A, Ricardi U, Wirth A, Oncology Group ILR Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89(1):49-58, 2014. PMID: 24725689.
23. Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS ACR Appropriateness Criteria: Localized nodal indolent lymphoma. Oncology (Williston Park) 27(8):786-794, 2013. PMID: 24133827.
24. Zreik TG, Mazloom A, Chen Y, Vannucci M, Pinnix CC, Fulton S, Hadziahmetovic M, Asmar N, Munkarah AR, Ayoub CM, Shihadeh F, Berjawi G, Hannoun A, Zalloua P, Wogan C, Dabaja B Fertility drugs and the risk of breast cancer: A meta-analysis and review. Breast Cancer Res Treat 124(1):13-26, 2010. PMID: 20809361.
25. Cox JD, Ha CS, Lee HK, Dabaja BS, Wilder RB Uncertainties in contemporary treatment of aggressive lymphomas. Rays 28(3):289-292, 2003. PMID: 15018315.
26. Taher A, Ammash Z, Dabaja B, Nasrallah A, Mourad FH Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review. Am J Hematol 63(2):90-93, 2000. PMID: 10629575.
27. Taher A, Shamsseddine A, Saghir N, Seoud M, Mourad F, Dabaja B, Khalil A Acquired protein C deficiency following cisplatinum-navelbine administration for locally advanced breast cancer. Case report. Eur J Gynaecol Oncol 20(4):323-324, 1999. PMID: 10475134.

Editorials

1. Dabaja BS. In The Battle of Proton Versus Photon? The Patient Must Win. Int Journal of Radiation Oncology, Biology, Physics, 2015.
2. Dabaja B. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: A multi-institutional, matched cohort study. Breast Quarterly 23(2):134-135, 2012.
3. Dabaja B. Comparison of three different mediastinal radiotherapy techniques in female patients: impact on heart sparing and dose of the breasts. Breast Diseases 19(3):264, 2008.

Abstracts

1. Wu SY, Gunther JR, Manzar GS, Corrigan KL, Damron EP, Schrank BR, Nasr LF, Chihara D, Malpica Castillo LE, Nair R, Steiner R, Jain P, Neelapu SS, Samanego F, Rodriguez MA, Strati P, Nastoupil L, Dabaja B, Pinnix CC, Fang P. Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. Int J Radiat Oncol Biol Phys 117(2S):e492, 2023. e-Pub 2023.
2. Manzar GS, Wu SY, Dudzinski SO, Jallouk A, Yoder AK, Nasr LF, Corrigan KL, Gunther JL, Ahmed S, Fayad L, Nair R, Steiner R, Westin J, Neelapu SS, Dabaja B, Strati P, Nastoupil L, Pinnix CC, Fang P, Rooney MK. Outcomes with Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Pts with Aggressive B Cell Lymphomas. Int J Radiat Oncol Biol Phys 117(2S):e483-e484, 2023. e-Pub 2023.
3. Schrank BR, Manzar GS, Wu SY, Gunther JR, Fang P, Jabbour EJ, Lim TY, Daver NG, Cykowski MD, Fuller GN, Cachia D, Kamiya-Matsuoka C, Woodman KH, DiNardo CD, Jain N, Short NJ, Sasaki K, Dabaja B, Kantarjian HM, Pinnix CC. Dorsal Column Myelopathy Following Intrathecal Chemotherapy for Leukemia. Int J Radiat Oncol Biol Phys 117(2S):e486-e487, 2023. e-Pub 2023.
4. Cha E, Manzar GS, Corrigan KL, Yoder AK, Schrank BR, Nasr LF, Gunther JR, Strati P, Ahmed S, Fayad L, Nair R, Steiner R, Westin J, Nastoupil L, Neelapu SS, Pinnix CC, Dabaja B, Wu SY, Fang P. Outcomes and Toxicities in Patients with Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract. Int J Radiat Oncol Biol Phys 117(2S):E460, 2023. e-Pub 2023.
5. Rafei H, Kantarjian HM, Sasaki K, Short NJ, Ravandi F, Huang XL, Khoury JD, Wang SA, Jorgensen JL, Khouri IF, Kebriaei P, Champlin RE, Jain N, Dabaja BS, Issa GC, Pemmaraju N, Tm K, Paul S, Jammal N, Garcia-Manero G, Wierda WG, DiNardo CD, Daver N, Montalban-Bravo G, Khouri R, Nasnas P, Thompson PA, Jacob J, Rostykus M, Garris R, Konopleva M, O'Brien SM, Jabbour E. Roleof Allogeneic Stem Cell Transplant (ASCT) in Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab (Blina): Results from a Phase 2 Study. BLOOD 136 Supl 1, 2020. e-Pub 2020.
6. Nair R, Pinnix CC, Gunther JR, Strati P, Westin J, Fayad L, Hagemeister FB, Iyer SP, Nastoupil LJ, Parmar S, Rodriguez MA, Steiner R, Dabaja BS, Fang P, Flowers C, Noorani M, Feng L, Neelapu SS, Ahmed S, Lee HJ. MD Anderson experience of immune checkpoint inhibitor therapy in classical Hodgkin lymphoma. J Clin Oncol, 2020. e-Pub 2020.
7. Steiner R, Cramer FM, Singh P, Becnel M, Alcedo PE, Chin CK, Cuglievan B, Strati P, Ahmed S, Samaniego F, Nair R, Gunther JR, Pinnix CC, Fang P, Dabaja BS, Feng L, Lee HJ. Brentuximab vedotin with chemotherapy for advanced stage untreated classic Hodgkin’s lymphoma in a real-world setting. J Clin Oncol 38(15S), 2020. e-Pub 2020.
8. Akhtari M, Reddy J, Dong W, Milgrom SA, Smith GL, Pinnix CC, Abou Yehia Z, Gunther JR, Osborne EM, Mawlawi OR, Rohren EM, Chuang HH, Garg N, Fanale M, Dabaja B. Restratifying Early-Stage Hodgkin Lymphoma Patients Using Novel Functional Imaging Parameters. Int J Radiat Oncol Biol Phys 96(2S), 2016. e-Pub 2016.
9. Pinnix CC, Abou Yehia Z, Smith GL, Milgrom SA, Ho JC, Reddy J, Gunther JR, Akhtari M, Osborne EM, Medeiros LJ, Fanale M, Dabaja B. More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone. International Journal of Radiation Oncology Biology Physics, 2016. e-Pub 2016.
10. Ho JC, Reddy J, Mazloom A, Allen PK, Milgrom SA, Smith GL, Medeiros LJ, Young KH, Fowler NH, Dabaja B, Pinnix CC. Radiation Therapy Improves Outcomes in Patients With Primary Testicular Diffuse Large B-cell Lymphoma. Int J Radiat Oncol Biol Phys 96(2S), 2016. e-Pub 2016.
11. Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi OR, Rohren EM, Garg N, Chuang HH, Abou Yehia Z, Reddy J, Gunther JR, Osborne EM, Oki Y, Fanale M, Dabaja B. Postchemotherapy Positron Emission Tomography/Computed Tomography Scans in Early-Stage Hodgkin Lymphoma: Moving Beyond the Deauville 5-Point Scale. International Journal of Radiation Oncology Biology Physics, 2016. e-Pub 2016.
12. Milgrom SA, Jauhari S, Plastaras JP, Lukens JN, Nieto Y, Dabaja B, Smith GL, Pinnix CC, Maity A, Nasta S. A Multi-institutional Analysis of Consolidative Radiation Therapy Following Autologous Transplantation for Relapsed/Refractory Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 96(2S):E495-E496, 2016. e-Pub 2016.
13. Milgrom SA, Smith GL, Pinnix CC, Dong W, Akhtari M, Mawlawi OR, Rohren EM, Garg N, Chuang HH, Reddy J, Gunther JR, Osborne EM, Abou Yehia Z, Oki Y, Fanale M, Dabaja B. Prognostic Significance of the Postchemotherapy Positron Emission Tomography (PET)/Computed Tomography in Early-Stage Hodgkin Lymphoma: Can PET-Positive Patients Be Cured With Radiation Alone?. Int J Radiat Oncol Biol Phys, 2016. e-Pub 2016.
14. Reddy JR, Gunther J, Dabaja B, Akhtari M, Martin GV, Allen PK, Aktinson BJ, Smith GL, Pinnix CC, Milgrom SA, Abou Yehia Z, Osborne EM, Fanale M. Pretreatment Neutrophil/Lymphocyte Ratio Predicts Relapse in Stage I and II Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 96(2S), 2016. e-Pub 2016.
15. Smith GL, Rahman AR, Dong W, Kebriaei P, Rondon G, Pinnix CC, Milgrom SA, Allen PK, Dabaja B. Proton Versus Photon Craniospinal Irradiation for Hematologic Malignancies Involving the CNS: Effectiveness and Toxicity in the Setting of Stem Cell Transplant. International Journal of Radiation Oncology Biology Physics, 2016. e-Pub 2016.
16. Pinnix CC, Abou Yehia Z, Qiao W, Milgrom SA, Smith GL, Akhtari M, Reddy J, Gunther JR, Osborne EM, Mawlawi OR, Medeiros LJ, Garg N, Chuang HH, Neelapu S, Westin JR, Dabaja B. Utilization of Positron Emission Tomography/Computed Tomography Parameters to Identify Patients at Risk for Progression After Treatment With Dose-Adjusted R-EPOCH for Primary Mediastinal B-Cell Lymphoma (PMBCL). Int J Radiat Oncol Biol Phys 96(2S), 2016. e-Pub 2016.
17. Sathyanarayanan V, Chihara D, Fanale MA, Costelloe CM, Ghonimi E, Shen C, Vega F, Dabaja BS, Oki Y, Zhou S, Hubert C. Prognostic value of PET-CT in early stage Hodgkin Lymphoma (HL) using updated 5 point scoring system. Journal of Clinical Oncology, 2016. e-Pub 2016.
18. Lee J, Aristophanous M, Akhtair M, Milgrom S, B <, Pinnix C, Narang S, Rao A, Court L, Smith G. SU-F-R-14: PET Based Radiomics to Predict Outcomes in Patients with Hodgkin Lymphoma. Med Phys 43(6):3376-3376, 2016. e-Pub 2016.
19. Milgrom S, Nieto Y, Pinnix C, Smith G, Reed V, Kebriaei P, Dabaja B. Graft-Versus-Host Disease Following Radiation Therapy in Patients with a History of Allogeneic Stem Cell Transplant. J Med Case Rep 10(209), 2016. e-Pub 2016. PMID: 27465468.
20. Abou Yehia ZA, Mikhaeel G, Smith G, Pinnix CC, Milgrom SA, Fanale MA, Reddy J, Osborne E, Akhtari M, Gunther J, Allen P, and Dabaja BS. Radiation Pneumonitis Risk after Bleomycin Toxicity in Hodgkin Lymphoma Patients. Blood, 2015. e-Pub 2015.
21. N/A. Extranodal Non-Hodgkin's Lymphoma: Clinical and Technical Advances in the Management of Primary Mediastinal lymphoma, gastric lymphoma, and Cutaneous. ASTRO 57th Annual Meeting, 2015. e-Pub 2015.
22. Horace P, Shank J, Turner S, |Dabaja B. Assessing for L'Hermitte's Sign. Oncology Nursing Forum 42(2):E189, 2015. e-Pub 2015.
23. Yehia ZA, Tang C, Milgrom SA, Fanale M, Smith GL, Pinnix CC, Reddy J, Akhtari M, Gunther JR, Osborne EM, Ahmed S, B <. Bone Involvement: A Poor Prognostic Factor in Stage IV Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 93(3S):E456, 2015. e-Pub 2015.
24. Akhtari M, Reddy J, Pinnix C, Allen P, Osborne E, Gunther J, Milgrom S, Smith G, Wogan C, Fowler N, Rodriguez A, Dabaja B. Excellent Outcomes in Primary Cutaneous B-Cell Lymphoma after very Low Dose Radiation. Int J Radiat Oncol Biol Phys 93(3S), 2015. e-Pub 2015.
25. Pinnix C, Dabaja B, Milgrom S, Smith G, Reed V, Arzu I, Westin J, Rondon G, Hosing C, Nieto Y, Ahmed S. Salvage Therapy Prior to Stem Cell Transplantation for Chemorefractory B-Cell Lymphoma. ASTRO 57th Annual Meeting, 2015. e-Pub 2015.
26. Pinnix C, Esmaeli B, Smith G, Milgrom S, Reed V, Arzu I, Shank J, Horace P, Allen K, Turner S, Morrell G, Fowler N, Dabaja B. Low dose 4 Gy Orbital Radiation for Therapy of Indolent B-Cell Lymphoma of the Ocular Adnexa. Int J Radiat Oncol Biol Phys 93(3S):E459, 2015. e-Pub 2015.
27. Pinnix CC, B <, Milgrom SA, Smith GL, Reed VK, Arzu IY, Westin JR, Rondon G, Hosing C, Nieto Y, Ahmed S. Salvage Radiation Therapy Prior to Stem Cell Transplantation for Chemorefractory B-Cell Lymphoma. Int J Radiat Oncol Biol Phys 93(3S):E459-E460, 2015. e-Pub 2015.
28. Weber D, Jatin S, Horowitz SB, Dabaja BS, Pinnix CC, Thomas SK, Manasanch OR, Esteve E, Qazilbash, Muzaffar H, Shah N, Ellen C, Atmar JS, Wang M, Milgrom SA, Feng L, Sevin A, Reed VK, YU J, LeeHans C. Clinical characteristics, outcomes and predictors of progression to multiple myeloma (MM) in 61 patients with solitary plasmacytoma. Clinical Lymphoma, Myeloma & Leukemia 15(3S):e181-182, 2015. e-Pub 2015.
29. Nieto Y, Bassett R, Anderlini P, Hosing CM, Alousi AM, Popat UR, Andersson BS, Valdez BC, Shpall EJ, Ahmed S, Qazilbash M, Guillermo M, Oki Y, Fanale MA, Hagemeister FB, Dabaja BS, Pinnix CC, Milgrom SA, Tewari P, Champlin RE, and Jones R. Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM. Blood, 2015. e-Pub 2015.
30. Bashey S, Tavallaee M, Duvic M, Dabaja B, Talpur R, Wilson L, Foss F, Girardi M, Li S, Rozati S, Million L, Hoppe R, Kim YH. A multicenter, open-label, randomized, phase I/II study evaluating the safety and efficacy of low-dose (12 Gy) total skin electron beam therapy (TSEBT) combined with vorinostat versus low-dose TSEBT monotherapy in patients with mycosis fungoides. 74th Annual Society for Investigative Dermatology Meeting 134(Suppl 1):S104, 2014. e-Pub 2014.
31. Court L, Yang J, Fullen D, Han N, Ko J, Mason S, Nguyen K, Stein S, Fave X, Hsieh M, Kuruvila S, Hillebrandt E, Palmer J, Beadle B, Dabaja B, Skinner H, Ibbott G, Balter P. Patients Could (and Should) Be Treated in An Upright Position. Medical Physics, 2013. e-Pub 2013.

Book Chapters

1. Wu S, Dabaja B, Fang P. Radiobiologic Principles and the Role of Radiotherapy in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy. In: Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Elsevier, 167-179, 2024.
2. Sullivan, TJ, Whitehead, K, Williamson, R, Grimes, D, Schlect, D, Brown, I, Dickie, G, Bhatia, S, Paulino, AC, Buatti, JM, Mayr, NA, Wen, BC, Pinnix, CC, Dabaja, BS, Milgrom, SA, Smith, GL, Abou, Z, Nastoupil, L, Romaguera, JE, Turturro, F, Fowler, N, Fayad, LE, Westin, JR, Neelapu, SS, Fanale, MA, Rodriguez, MA, Hagemeister, FB, Lee, HJ, Oki, Y, Wang, L, Samaniego, F, Chi, L, Esmaeli, B. Orbital adnexal lymphoma, 375-388, 2022.
3. Dabaja BS, Wilson LD. Mycosis Fungoides. In: Clinical Radiation Oncology. 5th. Elsevier, 1564-1586, 2020.
4. Sheu T, Gunther J, Dabaja B. Hodgkin Lymphoma. In: Pocket Radiation Oncology. Wolters Kluwer, 12-1, 2019.
5. Dabaja BS. Role of Radiation in the Treatment of Leukemias: Lymphoblastic Lymphoma, Central Nervous System Disease, and Chloromas. In: Radiation Therapy in Hematologic Malignancies. Springer, 97-114, 2017.
6. Smith GL, Wilson LD, Dabaja B. Mycosis fungoides. In: Clinical Radiation Oncology. 4. Gunderson & Tepper, 1556-1576, 2016.
7. Younes A, Carbone A, Dabaja B, Johnson P, Ansell S, Kuruvilla J. Hodgkin’s lymphoma. In: De Vita's Principle and Practice of Oncology. 10th. Lippincott Williams & Wilkins, 1526-51, 2015.
8. Dabaja B, Younes A, Coiffier. Cutaneous B cell lymphomas. In: Lymphoma: Diagnosis and Treatment. Humana Press/ Springer, 2013.
9. Pinnix CC, Dabaja B. Leukemia including lymphoblastic lymphoma. In: Hematologic Malignancies. 9. Demos Medical Publishing, 2012.
10. Dabaja B. Mycosis fungoides, presentation, diagnosis, and treatment strategy. In: Hematologic Malignancies. 3. Demos Medical Publishing, 2012.
11. Dabaja B. Diffuse large B-cell lymphoma: Nodal and extranodal including primary mediastinal lymphoma. In: Hematologic Malignancies. 3. Demos Medical Publishing, 2012.
12. Fanale M, Dabaja B, Anderolini P, Popat UR. Lymphoma: Hodgkin lymphoma. In: 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center. Springer Science and Business Media, 2012.
13. Pinnix CC, Dabaja B. Marginal zone lymphoma. In: Hematologic Malignancies. 3. Demos Medical Publishing, 2012.
14. Fayad LE, Konoplev S, Chuang HH, Rodriguez MA, commentary by Dabaja BS. Aggressive and highly aggressive B cell lymphomas. In: The MD Anderson Manual of Medical Oncology. 2nd. McGraw-Hill Medical, 147-182, 2011.
15. Dabaja B, Ha CS, Cox JD. Leukemia and lymphoma. In: Radiation Oncology. 9th. Elsevier, 875-911, 2009.
16. Dabaja B, Ha C. Leukemias and plasma cell disorders. In: Handbook of Radiation Oncology: Basic Principles and Clinical Protocols. Jones and Barlett Publishers, 739-754, 2009.

Books (edited and written)

1. Wu, SY, Dabaja, BS, Fang, PQ. Radiobiologic Principles and the Role of Radiotherapy in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy, 2023.
2. Dabaja BS, Ng A. Radiation Therapy in Hematologic Malignancies: An illustrated guide. Springer, 2016.
3. Tomblyn M, Winkfield K, Dabaja B. Hematologic Malignancies. Ed(s) 3. Demos Medical Publishing, 2012.

Letters to the Editor

1. Mehta RS, Torres CA, DiNardo CD, Daver N, Dabaja B, Rezvani K, Champlin RE, Shpall E, Duvic M. Post‐transplantation donor derived Sezary syndrome in a patient with A91V PRF1 variant Hemophagocytic lymphohistiocytosis. Am J Hematol 96: E350-E353, 2021.
2. Strati P, Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister FB, Romaguera J, Fayad LE, Rodriguez MA, Samaniego F, Fowler N, Westin J, Wang M, Lee HJ, Pinnix C, Gunther JR, B <, Feng L, Davis RE, Neelapu SS. Frontline Antibiotic Therapy for Early-Stage Helicobacter Pylori Negative Gastric MALT Lymphoma. Am J Hematol 94: 625-734, E150-E182, 2019.